184.52
Align Technology Inc stock is traded at $184.52, with a volume of 1.35M.
It is up +1.67% in the last 24 hours and up +10.70% over the past month.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
See More
Previous Close:
$181.49
Open:
$183.105
24h Volume:
1.35M
Relative Volume:
1.29
Market Cap:
$13.21B
Revenue:
$4.10B
Net Income/Loss:
$429.89M
P/E Ratio:
30.92
EPS:
5.9668
Net Cash Flow:
$583.65M
1W Performance:
+5.01%
1M Performance:
+10.70%
6M Performance:
+18.26%
1Y Performance:
-6.33%
Align Technology Inc Stock (ALGN) Company Profile
Name
Align Technology Inc
Sector
Industry
Phone
408-470-1000
Address
410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE, CA
Compare ALGN vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ALGN
Align Technology Inc
|
184.52 | 12.08B | 4.10B | 429.89M | 583.65M | 5.9668 |
|
ISRG
Intuitive Surgical Inc
|
426.01 | 140.84B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
158.08 | 41.70B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
MDLN
Medline Inc
|
43.19 | 33.35B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
ALC
Alcon Inc
|
69.66 | 32.72B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
RMD
Resmed Inc
|
209.63 | 28.27B | 5.54B | 1.52B | 1.74B | 10.37 |
Align Technology Inc Stock (ALGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-26 | Initiated | Citigroup | Buy |
| Mar-17-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Feb-09-26 | Upgrade | HSBC Securities | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Oct-10-25 | Downgrade | Jefferies | Buy → Hold |
| Jul-31-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-25-25 | Downgrade | HSBC Securities | Buy → Hold |
| Feb-14-25 | Initiated | Wells Fargo | Overweight |
| Jan-06-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Oct-10-24 | Initiated | Needham | Hold |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-11-23 | Downgrade | Goldman | Neutral → Sell |
| Oct-27-23 | Downgrade | UBS | Buy → Neutral |
| Feb-02-23 | Upgrade | Goldman | Sell → Neutral |
| Jul-28-22 | Downgrade | Goldman | Buy → Sell |
| Jan-31-22 | Initiated | Morgan Stanley | Overweight |
| Jan-31-22 | Upgrade | UBS | Neutral → Buy |
| Oct-01-21 | Resumed | Credit Suisse | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-09-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jul-08-21 | Initiated | Exane BNP Paribas | Outperform |
| Apr-22-21 | Upgrade | Berenberg | Hold → Buy |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-29-20 | Downgrade | Berenberg | Buy → Hold |
| Jul-20-20 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-09-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-24-19 | Reiterated | BofA/Merrill | Neutral |
| Oct-07-19 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-25-19 | Downgrade | Evercore ISI | Outperform → In-line |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Feb-14-19 | Downgrade | UBS | Buy → Neutral |
| Jan-17-19 | Initiated | UBS | Buy |
| Nov-20-18 | Reiterated | Credit Suisse | Outperform |
| Jul-26-18 | Reiterated | Stifel | Buy |
| Jul-13-18 | Reiterated | Stifel | Buy |
| Jun-25-18 | Resumed | BofA/Merrill | Buy |
| May-22-18 | Reiterated | Stifel | Buy |
| May-17-18 | Initiated | Evercore ISI | Outperform |
| Apr-26-18 | Reiterated | Stifel | Buy |
| Apr-20-18 | Initiated | Berenberg | Buy |
| Apr-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-08-18 | Initiated | Barclays | Overweight |
View All
Align Technology Inc Stock (ALGN) Latest News
Align Technology Inc. stock outperforms competitors on strong trading day - MSN
Align Technology Inc (ALGN) Stock Up 7.6% and Still Undervalued -- GF Score: 89/100 - GuruFocus
Align Technology jumps as investors appear to look past EU probe and refocus on company updates - Quiver Quantitative
Align Technology (ALGN) Set to Release Q2 2026 Financial Results - GuruFocus
Invisalign Maker Align Denies Wrongdoing, Defends Competition Practices As Europe Launches Probe - Benzinga
Align Technology to Announce Second Quarter 2026 Results on July 29, 2026 - Business Wire
European Commission opens antitrust investigation of Align Technology clear aligners - MassDevice
Align Technology says its practices comply with EU competition law - MLex
Invisalign Maker Faces EU Antitrust Probe - WSJ
EU opens antitrust probe into Align Technology over Invisalign, scanner tying - The Edge Malaysia
Align Technology Statement on European Commission Proceeding - 01net
Price to book forward of Align Technology, Inc. – NASDAQ:ALGN - TradingView
Align Technology (ALGN) Responds to European Commission Investigation - GuruFocus
Align Technology Says European Commission Opens Investigation Into Align Technology - TradingView
Align Technology Inc. stock outperforms competitors despite losses on the day - MarketWatch
EU investigates Align Technology for allegedly restricting competition in the orthodontics sector - marketscreener.com
Align Technology (ALGN) Faces EU Antitrust Investigation Over Co - GuruFocus
Align Technology (ALGN) Faces Antitrust Scrutiny in Europe - GuruFocus
Align Technology (ALGN) Faces Extended EU Antitrust Review - GuruFocus
Align Technology (ALGN) Faces EU Antitrust Investigation - GuruFocus
Out of line? EU probes Invisalign dental braces maker for antitrust breach - The Straits Times
European Commission opens antitrust probe into Align Technology's Invisalign, iTero practices in EEA - Traders Union
EU Opens Probe Into Align, Shares Retreat - TradingPedia
Why your dentist might have been forced to buy a specific scanner to order Invisalign - upday News
Align Technology, Inc. (ALGN) Latest Stock News & Headlines - Yahoo Finance
Align Technology stock falls after EU antitrust probe opens By Investing.com - Investing.com Canada
US medical device company Align Technology hit with EU probe over possible bundling - MLex
Align Technology consensus in focus, NASDAQ shares under analyst scrutiny - AD HOC NEWS
Price to earnings forward of Align Technology, Inc. – NASDAQ:ALGN - TradingView
Align Technology stock drops 2.80% amid 2026 Ortho Summit promo, AlignTechInc event - Traders Union
European Commission Launches Antitrust Investigation into Align Technology - Intellectia AI
Align Technology stock price forecast: $172.14 support tested as ALGN sheds 3.23% - Traders Union
Align Technology Inc. stock underperforms Monday when compared to competitors - MarketWatch
3 Reasons to Avoid ALGN and 1 Stock to Buy Instead - Yahoo Finance
Align Technology sets Q2 earnings date, shares trade steadily on Nasdaq - AD HOC NEWS
Align Technology, Inc. (ALGN) Stock Analysis: Exploring A 17% Potential Upside - DirectorsTalk Interviews
Invisalign Moderate from Align Technology Inc.tailored for mid-complex cases - AD HOC NEWS
How Align’s Chairman Transition to Kevin Conroy May Reshape Its Governance Story At Align Technology (ALGN) - simplywall.st
Align Technology analyst consensus in focus, shares trade on NASDAQ - Ad-hoc-news.de
Is Align Technology stock underperforming the Dow? - MSN
The Invisalign System from Align Technology Inc.clear aligners with digital planning - AD HOC NEWS
Align Technology opens the week with a clear earnings calendar, shares trade on Nasdaq - AD HOC NEWS
Align Technology Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Align Technology, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/4 Sh - TradingView
Align Technology, Inc. Actuals & Estimates (NASDAQ:ALGN) - TradingView
Align Technology stock rebounds 2.81 percent as Women's Smile Collective hosts New York event, AlignTechInc says - Traders Union
ALGN Forecast — Price Target — Prediction for 2027 - TradingView
Align Technology Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Responsive Playbooks and the ALGN Inflection - Stock Traders Daily
The Vivera Retainers from Align Technology Inc.long-term accessory for clear aligner patients - Ad-hoc-news.de
Is Align Technology Inc (ALGN) a Bargain After 3.0% Drop? GF Val - GuruFocus
Align Technology Inc Stock (ALGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Align Technology Inc Stock (ALGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SIEGEL SUSAN E | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
10,723 |
| Saia Andrea Lynn | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
17,318 |
| Poul Mojdeh | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
3,553 |
| Myong Anne | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
9,830 |
| LARKIN C RAYMOND JR | Director |
May 20 '26 |
Option Exercise |
0.00 |
2,326 |
0 |
27,454 |
| Dallas Kevin J | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
16,168 |
| LACOB JOSEPH | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
135,916 |
| Conroy Kevin T | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
3,553 |
| MORROW GEORGE J | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
5,036 |
| Morici John | EVP, CHIEF FINANCIAL OFFICER |
Feb 20 '26 |
Option Exercise |
0.00 |
7,848 |
0 |
16,085 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):